Mechanism of Action of Clozapine in Schizophrenia Treatment

Receptor Binding Profile and Therapeutic Effects

Clozapine's efficacy in treating both positive and negative symptoms of schizophrenia likely stems from its complex receptor binding profile, with weak antagonism of D2 receptors combined with potent 5-HT2 receptor inhibition, according to the American Academy of Child and Adolescent Psychiatry 1
The unique receptor binding profile explains why clozapine produces fewer extrapyramidal symptoms than typical antipsychotics, as noted by the American Academy of Child and Adolescent Psychiatry 1

Clozapine's efficacy for treatment-resistant schizophrenia makes it a preferred option for patients who fail to respond to at least two other antipsychotic medications, as recommended by clinical guidelines 2
The drug's ability to treat both positive and negative symptoms of schizophrenia is likely related to its balanced effects on multiple neurotransmitter systems, according to the American Academy of Child and Adolescent Psychiatry 1

Clozapine has a poor cardiometabolic profile, with significant effects on weight, glucose metabolism, and lipids, which may be related to its actions on histaminergic, serotonergic, and other receptor systems 3